Loading…

The role of antioxidant vitamins in gynecologic malignancies

Vitamins D, C, E and A, which belong to antioxidants, exhibit anticancer activity. The mechanism of vitamin D antitumor activity involves the inhibition of cell proliferation, stimulation of apoptosis, inhibition of angiogenesis and an increased activity of metalloproteinases in the extracellular ma...

Full description

Saved in:
Bibliographic Details
Published in:Current Gynecologic Oncology 2016-04, Vol.14 (1), p.39-52
Main Authors: Markowska, Anna, Jaszczyńska-Nowinka, Karolina, Kaysiewicz, Joanna, Makówka, Anna, Markowska, Janina
Format: Article
Language:eng ; pol
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 52
container_issue 1
container_start_page 39
container_title Current Gynecologic Oncology
container_volume 14
creator Markowska, Anna
Jaszczyńska-Nowinka, Karolina
Kaysiewicz, Joanna
Makówka, Anna
Markowska, Janina
description Vitamins D, C, E and A, which belong to antioxidants, exhibit anticancer activity. The mechanism of vitamin D antitumor activity involves the inhibition of cell proliferation, stimulation of apoptosis, inhibition of angiogenesis and an increased activity of metalloproteinases in the extracellular matrix. Vitamin D prevents the development and progression of breast cancer; its lower levels in the serum of premenopausal women are linked to the development of triple negative cancer (E-, PR-, HER2-). Cohort studies on the effects of VDR (vitamin D receptor) polymorphisms and studies related to vitamin D supplementation in postmenopausal women in the context of reduced risk of breast cancer are controversial. Vitamin D exerts a protective effect against ovarian and endometrial cancer. Vitamin C protects cells against the formation of mutagenic nitro compounds, enhances the immune system by promoting the activity of NK, T and B cells. Vitamin C supplementation improves treatment outcomes in disseminated breast cancer; the vitamin acts synergistically with cisplatin, it increases paclitaxel and doxorubicin cytotoxicity and abolishes toxic effects of tamoxifen. Vitamin C combined with chemotherapy in ovarian cancer prolongs patient’s survival. It increases sensitivity to cisplatin. Vitamin E exerts anticancer effects via multiple pathways. Its increased administration reduces the risk of breast cancer and ovarian cancer. The reduction in the incidence of endometrial cancer remains controversial. Vitamin A also exerts antioxidant effects. The compound reduces the incidence of DNA damage in cells exposed to hydrogen peroxide and protects cell organelles (including mitochondria) against the negative impact of lipid peroxidation. It reduces the risk of multiple tumors, including breast and cervical cancer.
doi_str_mv 10.15557/CGO.2016.0005
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2708641269</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2708641269</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1075-c9d4838e3ba5b17d05cf26678eabe5e9e1a467cb2f46e8c1239d2734514839c73</originalsourceid><addsrcrecordid>eNotkEtLAzEURoMoWGq3rgOuZ8w7M-BGilah0E1dh0zmTk2ZJjVpxf57U-vqu4tzXwehe0pqKqXUj_PFqmaEqpoQIq_QhAlJK6IluS41aWhFFWe3aJbzthCsVYJpMUFP60_AKY6A44BtOPj44_uS-Nsf7M6HjH3Am1MAF8e48Q7v7Og3wQbnId-hm8GOGWb_OUUfry_r-Vu1XC3e58_LytFyQeXaXjS8Ad5Z2VHdE-kGppRuwHYgoQVqhdKuY4NQ0DjKeNszzcsDpa11mk_Rw2XuPsWvI-SD2cZjCmWlYZo0SlCm2kLVF8qlmHOCweyT39l0MpSYP0mmSDJnSeYsif8CgmJYVA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2708641269</pqid></control><display><type>article</type><title>The role of antioxidant vitamins in gynecologic malignancies</title><source>Publicly Available Content Database</source><creator>Markowska, Anna ; Jaszczyńska-Nowinka, Karolina ; Kaysiewicz, Joanna ; Makówka, Anna ; Markowska, Janina</creator><creatorcontrib>Markowska, Anna ; Jaszczyńska-Nowinka, Karolina ; Kaysiewicz, Joanna ; Makówka, Anna ; Markowska, Janina ; Klinika Onkologii, Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Poznań, Polska. Kierownik Kliniki: prof. dr hab. n. med. Rodryg Ramlau ; Klinika Perinatologii i Chorób Kobiecych, Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Poznań, Polska. Kierownik Kliniki: prof. dr hab. n. med. Krzysztof Drews ; Roche Polska, Warszawa, Polska</creatorcontrib><description>Vitamins D, C, E and A, which belong to antioxidants, exhibit anticancer activity. The mechanism of vitamin D antitumor activity involves the inhibition of cell proliferation, stimulation of apoptosis, inhibition of angiogenesis and an increased activity of metalloproteinases in the extracellular matrix. Vitamin D prevents the development and progression of breast cancer; its lower levels in the serum of premenopausal women are linked to the development of triple negative cancer (E-, PR-, HER2-). Cohort studies on the effects of VDR (vitamin D receptor) polymorphisms and studies related to vitamin D supplementation in postmenopausal women in the context of reduced risk of breast cancer are controversial. Vitamin D exerts a protective effect against ovarian and endometrial cancer. Vitamin C protects cells against the formation of mutagenic nitro compounds, enhances the immune system by promoting the activity of NK, T and B cells. Vitamin C supplementation improves treatment outcomes in disseminated breast cancer; the vitamin acts synergistically with cisplatin, it increases paclitaxel and doxorubicin cytotoxicity and abolishes toxic effects of tamoxifen. Vitamin C combined with chemotherapy in ovarian cancer prolongs patient’s survival. It increases sensitivity to cisplatin. Vitamin E exerts anticancer effects via multiple pathways. Its increased administration reduces the risk of breast cancer and ovarian cancer. The reduction in the incidence of endometrial cancer remains controversial. Vitamin A also exerts antioxidant effects. The compound reduces the incidence of DNA damage in cells exposed to hydrogen peroxide and protects cell organelles (including mitochondria) against the negative impact of lipid peroxidation. It reduces the risk of multiple tumors, including breast and cervical cancer.</description><identifier>ISSN: 2081-1632</identifier><identifier>EISSN: 2451-0750</identifier><identifier>EISSN: 2081-1632</identifier><identifier>DOI: 10.15557/CGO.2016.0005</identifier><language>eng ; pol</language><publisher>Warsaw: Medical Communications Sp. z o.o</publisher><subject>Breast cancer ; Cervical cancer ; Endometrial cancer ; Ovarian cancer ; Vitamin C ; Vitamin D</subject><ispartof>Current Gynecologic Oncology, 2016-04, Vol.14 (1), p.39-52</ispartof><rights>2016. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2708641269?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,25752,27923,27924,37011,44589</link.rule.ids></links><search><creatorcontrib>Markowska, Anna</creatorcontrib><creatorcontrib>Jaszczyńska-Nowinka, Karolina</creatorcontrib><creatorcontrib>Kaysiewicz, Joanna</creatorcontrib><creatorcontrib>Makówka, Anna</creatorcontrib><creatorcontrib>Markowska, Janina</creatorcontrib><creatorcontrib>Klinika Onkologii, Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Poznań, Polska. Kierownik Kliniki: prof. dr hab. n. med. Rodryg Ramlau</creatorcontrib><creatorcontrib>Klinika Perinatologii i Chorób Kobiecych, Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Poznań, Polska. Kierownik Kliniki: prof. dr hab. n. med. Krzysztof Drews</creatorcontrib><creatorcontrib>Roche Polska, Warszawa, Polska</creatorcontrib><title>The role of antioxidant vitamins in gynecologic malignancies</title><title>Current Gynecologic Oncology</title><description>Vitamins D, C, E and A, which belong to antioxidants, exhibit anticancer activity. The mechanism of vitamin D antitumor activity involves the inhibition of cell proliferation, stimulation of apoptosis, inhibition of angiogenesis and an increased activity of metalloproteinases in the extracellular matrix. Vitamin D prevents the development and progression of breast cancer; its lower levels in the serum of premenopausal women are linked to the development of triple negative cancer (E-, PR-, HER2-). Cohort studies on the effects of VDR (vitamin D receptor) polymorphisms and studies related to vitamin D supplementation in postmenopausal women in the context of reduced risk of breast cancer are controversial. Vitamin D exerts a protective effect against ovarian and endometrial cancer. Vitamin C protects cells against the formation of mutagenic nitro compounds, enhances the immune system by promoting the activity of NK, T and B cells. Vitamin C supplementation improves treatment outcomes in disseminated breast cancer; the vitamin acts synergistically with cisplatin, it increases paclitaxel and doxorubicin cytotoxicity and abolishes toxic effects of tamoxifen. Vitamin C combined with chemotherapy in ovarian cancer prolongs patient’s survival. It increases sensitivity to cisplatin. Vitamin E exerts anticancer effects via multiple pathways. Its increased administration reduces the risk of breast cancer and ovarian cancer. The reduction in the incidence of endometrial cancer remains controversial. Vitamin A also exerts antioxidant effects. The compound reduces the incidence of DNA damage in cells exposed to hydrogen peroxide and protects cell organelles (including mitochondria) against the negative impact of lipid peroxidation. It reduces the risk of multiple tumors, including breast and cervical cancer.</description><subject>Breast cancer</subject><subject>Cervical cancer</subject><subject>Endometrial cancer</subject><subject>Ovarian cancer</subject><subject>Vitamin C</subject><subject>Vitamin D</subject><issn>2081-1632</issn><issn>2451-0750</issn><issn>2081-1632</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNotkEtLAzEURoMoWGq3rgOuZ8w7M-BGilah0E1dh0zmTk2ZJjVpxf57U-vqu4tzXwehe0pqKqXUj_PFqmaEqpoQIq_QhAlJK6IluS41aWhFFWe3aJbzthCsVYJpMUFP60_AKY6A44BtOPj44_uS-Nsf7M6HjH3Am1MAF8e48Q7v7Og3wQbnId-hm8GOGWb_OUUfry_r-Vu1XC3e58_LytFyQeXaXjS8Ad5Z2VHdE-kGppRuwHYgoQVqhdKuY4NQ0DjKeNszzcsDpa11mk_Rw2XuPsWvI-SD2cZjCmWlYZo0SlCm2kLVF8qlmHOCweyT39l0MpSYP0mmSDJnSeYsif8CgmJYVA</recordid><startdate>20160429</startdate><enddate>20160429</enddate><creator>Markowska, Anna</creator><creator>Jaszczyńska-Nowinka, Karolina</creator><creator>Kaysiewicz, Joanna</creator><creator>Makówka, Anna</creator><creator>Markowska, Janina</creator><general>Medical Communications Sp. z o.o</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope></search><sort><creationdate>20160429</creationdate><title>The role of antioxidant vitamins in gynecologic malignancies</title><author>Markowska, Anna ; Jaszczyńska-Nowinka, Karolina ; Kaysiewicz, Joanna ; Makówka, Anna ; Markowska, Janina</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1075-c9d4838e3ba5b17d05cf26678eabe5e9e1a467cb2f46e8c1239d2734514839c73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng ; pol</language><creationdate>2016</creationdate><topic>Breast cancer</topic><topic>Cervical cancer</topic><topic>Endometrial cancer</topic><topic>Ovarian cancer</topic><topic>Vitamin C</topic><topic>Vitamin D</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Markowska, Anna</creatorcontrib><creatorcontrib>Jaszczyńska-Nowinka, Karolina</creatorcontrib><creatorcontrib>Kaysiewicz, Joanna</creatorcontrib><creatorcontrib>Makówka, Anna</creatorcontrib><creatorcontrib>Markowska, Janina</creatorcontrib><creatorcontrib>Klinika Onkologii, Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Poznań, Polska. Kierownik Kliniki: prof. dr hab. n. med. Rodryg Ramlau</creatorcontrib><creatorcontrib>Klinika Perinatologii i Chorób Kobiecych, Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Poznań, Polska. Kierownik Kliniki: prof. dr hab. n. med. Krzysztof Drews</creatorcontrib><creatorcontrib>Roche Polska, Warszawa, Polska</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><jtitle>Current Gynecologic Oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Markowska, Anna</au><au>Jaszczyńska-Nowinka, Karolina</au><au>Kaysiewicz, Joanna</au><au>Makówka, Anna</au><au>Markowska, Janina</au><aucorp>Klinika Onkologii, Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Poznań, Polska. Kierownik Kliniki: prof. dr hab. n. med. Rodryg Ramlau</aucorp><aucorp>Klinika Perinatologii i Chorób Kobiecych, Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Poznań, Polska. Kierownik Kliniki: prof. dr hab. n. med. Krzysztof Drews</aucorp><aucorp>Roche Polska, Warszawa, Polska</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The role of antioxidant vitamins in gynecologic malignancies</atitle><jtitle>Current Gynecologic Oncology</jtitle><date>2016-04-29</date><risdate>2016</risdate><volume>14</volume><issue>1</issue><spage>39</spage><epage>52</epage><pages>39-52</pages><issn>2081-1632</issn><eissn>2451-0750</eissn><eissn>2081-1632</eissn><abstract>Vitamins D, C, E and A, which belong to antioxidants, exhibit anticancer activity. The mechanism of vitamin D antitumor activity involves the inhibition of cell proliferation, stimulation of apoptosis, inhibition of angiogenesis and an increased activity of metalloproteinases in the extracellular matrix. Vitamin D prevents the development and progression of breast cancer; its lower levels in the serum of premenopausal women are linked to the development of triple negative cancer (E-, PR-, HER2-). Cohort studies on the effects of VDR (vitamin D receptor) polymorphisms and studies related to vitamin D supplementation in postmenopausal women in the context of reduced risk of breast cancer are controversial. Vitamin D exerts a protective effect against ovarian and endometrial cancer. Vitamin C protects cells against the formation of mutagenic nitro compounds, enhances the immune system by promoting the activity of NK, T and B cells. Vitamin C supplementation improves treatment outcomes in disseminated breast cancer; the vitamin acts synergistically with cisplatin, it increases paclitaxel and doxorubicin cytotoxicity and abolishes toxic effects of tamoxifen. Vitamin C combined with chemotherapy in ovarian cancer prolongs patient’s survival. It increases sensitivity to cisplatin. Vitamin E exerts anticancer effects via multiple pathways. Its increased administration reduces the risk of breast cancer and ovarian cancer. The reduction in the incidence of endometrial cancer remains controversial. Vitamin A also exerts antioxidant effects. The compound reduces the incidence of DNA damage in cells exposed to hydrogen peroxide and protects cell organelles (including mitochondria) against the negative impact of lipid peroxidation. It reduces the risk of multiple tumors, including breast and cervical cancer.</abstract><cop>Warsaw</cop><pub>Medical Communications Sp. z o.o</pub><doi>10.15557/CGO.2016.0005</doi><tpages>14</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2081-1632
ispartof Current Gynecologic Oncology, 2016-04, Vol.14 (1), p.39-52
issn 2081-1632
2451-0750
2081-1632
language eng ; pol
recordid cdi_proquest_journals_2708641269
source Publicly Available Content Database
subjects Breast cancer
Cervical cancer
Endometrial cancer
Ovarian cancer
Vitamin C
Vitamin D
title The role of antioxidant vitamins in gynecologic malignancies
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T20%3A42%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20role%20of%20antioxidant%20vitamins%20in%20gynecologic%20malignancies&rft.jtitle=Current%20Gynecologic%20Oncology&rft.au=Markowska,%20Anna&rft.aucorp=Klinika%20Onkologii,%20Uniwersytet%20Medyczny%20im.%20Karola%20Marcinkowskiego%20w%20Poznaniu,%20Pozna%C5%84,%20Polska.%20Kierownik%20Kliniki:%20prof.%20dr%20hab.%20n.%20med.%20Rodryg%20Ramlau&rft.date=2016-04-29&rft.volume=14&rft.issue=1&rft.spage=39&rft.epage=52&rft.pages=39-52&rft.issn=2081-1632&rft.eissn=2451-0750&rft_id=info:doi/10.15557/CGO.2016.0005&rft_dat=%3Cproquest_cross%3E2708641269%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1075-c9d4838e3ba5b17d05cf26678eabe5e9e1a467cb2f46e8c1239d2734514839c73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2708641269&rft_id=info:pmid/&rfr_iscdi=true